In a world increasingly captivated by health and wellness trends, herbal pills have emerged as a popular choice for many seeking natural alternatives to pharmaceuticals. According to experts, Tthese pills, derived from a variety of plants, are often seen as harmless due to their natural origins. However, this perception can be misleading and potentially harmful. Unlike conventional medications, people often assume that herbal pills can be consumed freely, without the constraints of prescribed dosages or professional medical advice. Yet, this assumption can lead to serious health consequences.
The rise in the use of herbal medicines and dietary supplements, commonly referred to as HDS, has coincided with an increase in liver-related health issues. In some severe cases, individuals have required liver transplants or have even succumbed to liver failure. Alarmingly, in the United States, instances of liver failure linked to HDS have increased eightfold in the past 25 years. Similarly, research in Korea indicates a parallel trend, highlighting the association between HDS overuse and drug-induced liver injuries. These injuries manifest in various forms, including abnormal liver enzyme levels and substantial liver damage.
The global market for herbal medicines and supplements was valued at a staggering $70.1 billion in 2022. Projections suggest it could soar to $389.75 billion by 2031. Europe leads in consumption, accounting for half of the global usage. As these products become more prevalent, concerns about drug-induced liver injuries grow, raising alarms on a global scale.
The COVID-19 pandemic further fueled the demand for HDS, as individuals sought ways to bolster their immune defences. In the United States alone, sales of these supplements exceeded $10 billion in 2020. This surge can be partly attributed to the classification of HDS by the US Food and Drug Administration (FDA) as food supplements rather than drugs. This distinction allows them to be sold over-the-counter without the rigorous regulations applied to prescription medications.
Herbal medicines draw from ancient healing traditions and are integral to public healthcare systems in countries like India, China, Korea, and Singapore. While many such medicines are recognised for their health benefits, misuse or overuse can lead to significant health risks. A renowned toxicologist once noted that “the dose makes the poison,” implying that the toxicity of any substance is dose-dependent. Factors like individual metabolism, absorption rates, and detoxification processes also play critical roles in whether a substance becomes harmful.
Surprisingly, even benign substances like water can become toxic when consumed in excess. Similarly, green tea extract, popular for weight loss, can adversely affect the liver in obese individuals with pre-existing liver conditions. The combination of obesity and liver damage leads to a build-up of foreign substances, known as xenobiotics, which can result in toxicity.
Ashwagandha, or Indian ginseng, is another example. Widely used in India and gaining popularity globally, it is celebrated for its anti-inflammatory properties and its ability to treat conditions like arthritis, diabetes, hypertension, and infertility. However, one of its key compounds, withanone, interacts with DNA and can cause severe biological repercussions such as DNA damage. Normally, this risk is mitigated by glutathione (GSH), a natural antioxidant found in cells. But excessive doses of ashwagandha extract can overwhelm the GSH system, leading to liver damage.
Quality control issues pose additional risks. Studies have revealed that many herbal formulations are tainted with harmful chemicals such as phenylbutazone and antibiotics. They may also contain toxic industrial solvents and metals like arsenic, mercury, and lead. Moreover, products often suffer from mislabelling or lack clear dosing instructions. Insufficient scientific validation and post-marketing surveillance exacerbate the challenges posed by an unregulated market.
Manufacturers bear the responsibility for ensuring product safety. Unfortunately, many do not conduct preclinical safety tests or efficacy studies before launching their supplements. Identifying toxicity causes in patients using HDS is challenging due to the myriad ingredients involved. Establishing guidelines for testing HDS toxicity levels, determining therapeutic doses, and evaluating herbal formulations is essential.
Given their growing popularity and increasing evidence of potential toxic effects, there is an urgent need for legislation regulating the herbal drug market. Consumers should receive scientifically accurate information about dosages, contraindications, and efficacy akin to those provided for over-the-counter medications.
Herbal pills offer an appealing alternative to conventional medicines with their promise of natural healing. However, they are not without risks. As they continue to grow in popularity worldwide, it becomes ever more critical to approach them with caution and informed judgement. The balance between tradition and modern science can be achieved through regulation and education—ensuring that the benefits of herbal medicines are safely harnessed without compromising public health.
By fostering an informed consumer base and implementing stringent regulations on herbal products, we can mitigate potential health risks while maintaining the rich heritage of traditional medicine practices. As herbal supplements continue to weave into the fabric of modern wellness routines, both consumers and manufacturers must take proactive steps to ensure safety and efficacy—thus preserving their therapeutic potential for generations to come.
